Published in:
01-02-2004 | Poster presentation
Use of national guidelines for the introduction of Drotrecogin alfa (activated)
Authors:
S Mackenzie, L Patterson, L Plenderleith, F MacKirdy
Published in:
Critical Care
|
Special Issue 1/2004
Login to get access
Excerpt
The Scottish Medicines Consortium approved the use of Drotrecogin alfa (activated) (Xigris
©) in October 2002 and recommended that a register of patients receiving the drug be kept. The Scottish Intensive Care Society (SICS) developed guidelines for the use of this innovative therapy, suggesting that patients should have three or more of the systemic inflammatory response syndrome (SIRS) criteria in the presence of infection, at least two acute organ failures and an APACHE score of at least 25 [
1]. …